K

Kiniksa Pharmaceuticals Ltd
D

KNSA

63.860
USD
1.02
(1.62%)
مفتوح الان
حجم التداول
5,078
الربح لكل سهم
1
العائد الربحي
-
P/E
70
حجم السوق
4,905,567,900
أصول ذات صلة المقالات
المزيد

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.